ArticleThe European journal of health economics : HEPAC : health economics in prevention and care2024
Canada population norms for the EQ-5D-5L.
Article in The European journal of health economics : HEPAC : health economics in prevention and care, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
27 citing papers in PubMed, 1 synthesis or guideline pooled it, 41 citations in OpenAlex.
- Deriving Health Utility Values Using Mapping Methods Among the Chinese Population: A Systematic Review.Applied health economics and health policy · 2026Pooled it
- From disability to daily life: functional status, quality of life and work productivity in real-world inflammatory arthritis.Rheumatology (Oxford, England) · 2026Article
- Economic evaluation of wastewater surveillance in Ontario, Canada, using COVID-19 as a case study.Canada communicable disease report = Releve des maladies transmissibles au Canada · 2026Article
- Health-related quality of life of older adults residing in social housing: a cross-sectional descriptive study using the EQ-5D-5L.Journal of patient-reported outcomes · 2026Article
- Cost-Effectiveness of the I'm Ready HIV Self-Testing Programme Among High-Risk Populations in Canada.Journal of the International AIDS Society · 2026Article
- Article
- Quality-adjusted life expectancy norms for the Canadian population using EQ-5D-5L and SF-6Dv2.The European journal of health economics : HEPAC : health economics in prevention and care · 2026Article
- Health-related quality of life in breast cancer measured with EQ-5D-5L.Journal of patient-reported outcomes · 2026Article
- The impact of testing positive versus negative for COVID-19 on health-related quality of life: cross-sectional evidence from the Alberta post-COVID-19 follow-up survey.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2026Article
- Development of an asthma policy model for Canada: Lifetime Exposures and Asthma outcomes Projection.PloS one · 2026Article
- Influence of the COVID-19 pandemic on chronic disease management among indigenous people in Canada.Frontiers in public health · 2026Article
- Hepatitis C Screening: A Health Technology Assessment.Ontario health technology assessment series · 2026Article
- Effectiveness and Cost-Effectiveness of a Stepped Model of Care for Musculoskeletal Disorders: Protocol for a Multiarm Randomized Controlled Trial (Edu-First Trial).JMIR research protocols · 2025Article
- Comparison of open fetal, fetoscopic and postnatal surgical repair for open spina bifida: decision analysis.Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology · 2025Article
- Population norms for the EQ-5D-5L for Hungary: comparison of online surveys and computer assisted personal interviews.The European journal of health economics : HEPAC : health economics in prevention and care · 2025Article
- Cost-Utility Analysis of COVID-19 Vaccination Strategies for Endemic SARS-CoV-2.JAMA network open · 2025Article
- Cost-effectiveness of respiratory syncytial virus vaccination strategies for older Canadian adults: A multi-model comparison.Canada communicable disease report = Releve des maladies transmissibles au Canada · 2025Article
- Comparison of 13-, 15- and 20-valent pneumococcal conjugate vaccines in the paediatric Canadian population: A cost-utility analysis.Canada communicable disease report = Releve des maladies transmissibles au Canada · 2025Article
- Addressing the need for economic modelling when designing and reporting a diagnostic testing accuracy study.Frontiers in public health · 2025Article
- Exploring social determinants of health and their impacts on self-reported quality of life in long COVID-19 patients.Scientific reports · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 4 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveIn Canada, population norms are only available for 2 provinces, Alberta and Quebec. The objective of this study was to derive the population norms for the EQ-5D-5L based on a representative sample of the Canadian general population.
methodsData from the Canadian EQ-5D-5L valuation study, a cross-sectional study, were used. A quota sampling method was used to recruit a representative sample of the Canadian general population in terms of age, sex, and education. EQ-5D-5L utilities and EQ VAS were summarized using descriptive statistics and the impact of demographic characteristics on the EQ-5D-5L utilities was evaluated using statistical hypothesis testing and Tobit regression.
results1207 eligible participants were included in the analysis. Pain/discomfort (53.1%) was the most frequently reported domain with any problem, and self-care (7.6%) domain was the least. The mean (standard deviation [SD]) EQ-5D-5L utility was 0.864 (0.121) and the mean (SD) EQ VAS was 82.3 (14.23). The highest mean EQ-5D-5L utility was 0.881 in age group 25-34 while the lowest was 0.839 in age group 55-64. Participants who had full-time employment, were married, a higher annual household income and no chronic health conditions had significantly higher EQ-5D-5L utilities.
conclusionThis article reports the first Canadian population norms for the EQ-5D-5L and can be used as population references for economic evaluations and clinical research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.